Extremely Low-Frequency Electromagnetic Fields Increase Cytokines in Human Hair Follicles through Wnt/β-Catenin Signaling.

Biomedicines · 2022 · Benefit · Very low evidence

← Research stream
BenefitVery low evidencePaper 5745

ELF-EMF exposure at 5–20 G did not induce toxicity in hair bulb spheroids and increased expression of ALP, versican, β-catenin, and several cytokines (VEGF, PDGF, FGF-10, ET-1), with decreased TUNEL staining. Hair follicles exposed for 60 min showed increased…

Study snapshot

PublicationBiomedicines · 2022
Study typein_vitro
Reported directionBenefit
Evidence ratingVery low

Abstract

Hair loss is a chronic disorder that affects many people; however, a complete treatment has not yet been developed. Therefore, new therapeutic agents for preventing hair loss must be developed, and electromagnetic field (EMF) therapy has been proven to be a promising medical treatment in various fields, including hair loss treatment. This study evaluated the effect of extremely low-frequency electromagnetic field (ELF-EMF) intensity and exposure time by analyzing the expression of cytokines and anagen-related molecules, which influence hair activation and growth, in hair bulb spheroid (HBS) and hair follicle (HF) organ cultures. ELF-EMFs did not induce toxicity in the HBSs, as verified via the lactate dehydrogenase (LDH) assay. Moreover, an ELF-EMF intensity of 5-20 G promoted the expression of ALP, versican, β-catenin, and several cytokines (VEGF, PDGF, FGF-10, and ET-1) in HBSs. Immunohistochemical staining showed that ELF-EMF at an intensity of 5-20 G upregulated ALP and β-catenin and decreased TUNEL staining in HBS. Moreover, HFs exposed to ELF-EMF for 60 min exhibited an increase in hair length and a 1.5-fold increase in IL-4, ICAM-1, ALP, and versican mRNA expression compared to the control. Immunohistochemical staining indicated that 60 min of ELF-EMF can increase the expression of ALP and β-catenin and decreases TUNEL staining in organ cultures. Collectively, our results demonstrated that ELF-EMF exposure at a 10 G intensity for 60 min promoted hair shaft growth in HFs due to the effect of cytokines and adhesion molecules via the Wnt/β-catenin pathway. Therefore, ELF-EMF is a promising treatment for hair loss.

Machine Enhanced Logic

AI evidence extraction

Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.

Study typein_vitro
Effect directionbenefit
PopulationNot supplied
Sample sizeNot supplied
ExposureELF · 60 min (also evaluated exposure time; specific other durations not stated)
Evidence strengthVery lowConfidence: 78% · Peer reviewed: yes

Main findings

ELF-EMF exposure at 5–20 G did not induce toxicity in hair bulb spheroids and increased expression of ALP, versican, β-catenin, and several cytokines (VEGF, PDGF, FGF-10, ET-1), with decreased TUNEL staining. Hair follicles exposed for 60 min showed increased hair length and ~1.5-fold increased IL-4, ICAM-1, ALP, and versican mRNA versus control; 10 G for 60 min was reported to promote hair shaft growth via cytokines/adhesion molecules through the Wnt/β-catenin pathway.

Outcomes measured

  • Toxicity (LDH assay) in hair bulb spheroids
  • Expression of ALP, versican, β-catenin in hair bulb spheroids and hair follicles
  • Cytokine expression (VEGF, PDGF, FGF-10, ET-1) in hair bulb spheroids
  • mRNA expression changes (IL-4, ICAM-1, ALP, versican) in hair follicles
  • Hair shaft length/growth in hair follicle organ culture
  • Apoptosis marker staining (TUNEL)
  • Wnt/β-catenin signaling involvement (β-catenin upregulation)

Limitations

  • In vitro/ex vivo model (hair bulb spheroid and hair follicle organ cultures), not a clinical study
  • ELF-EMF frequency not reported in abstract
  • Sample size and detailed exposure protocol (e.g., number of replicates, full time-course) not reported in abstract
View raw extracted JSON
{
  "study_type": "in_vitro",
  "exposure": {
    "band": "ELF",
    "source": null,
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": "60 min (also evaluated exposure time; specific other durations not stated)"
  },
  "population": null,
  "sample_size": null,
  "outcomes": [
    "Toxicity (LDH assay) in hair bulb spheroids",
    "Expression of ALP, versican, β-catenin in hair bulb spheroids and hair follicles",
    "Cytokine expression (VEGF, PDGF, FGF-10, ET-1) in hair bulb spheroids",
    "mRNA expression changes (IL-4, ICAM-1, ALP, versican) in hair follicles",
    "Hair shaft length/growth in hair follicle organ culture",
    "Apoptosis marker staining (TUNEL)",
    "Wnt/β-catenin signaling involvement (β-catenin upregulation)"
  ],
  "main_findings": "ELF-EMF exposure at 5–20 G did not induce toxicity in hair bulb spheroids and increased expression of ALP, versican, β-catenin, and several cytokines (VEGF, PDGF, FGF-10, ET-1), with decreased TUNEL staining. Hair follicles exposed for 60 min showed increased hair length and ~1.5-fold increased IL-4, ICAM-1, ALP, and versican mRNA versus control; 10 G for 60 min was reported to promote hair shaft growth via cytokines/adhesion molecules through the Wnt/β-catenin pathway.",
  "effect_direction": "benefit",
  "limitations": [
    "In vitro/ex vivo model (hair bulb spheroid and hair follicle organ cultures), not a clinical study",
    "ELF-EMF frequency not reported in abstract",
    "Sample size and detailed exposure protocol (e.g., number of replicates, full time-course) not reported in abstract"
  ],
  "evidence_strength": "very_low",
  "confidence": 0.78,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "ELF-EMF",
    "extremely low-frequency electromagnetic field",
    "hair follicle",
    "hair bulb spheroid",
    "hair growth",
    "cytokines",
    "VEGF",
    "PDGF",
    "FGF-10",
    "ET-1",
    "IL-4",
    "ICAM-1",
    "ALP",
    "versican",
    "β-catenin",
    "Wnt/β-catenin",
    "TUNEL",
    "LDH assay"
  ],
  "suggested_hubs": []
}
AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.

Identifiers and source

DOI: 10.3390/biomedicines10040924
PubMed: 35453674

Read the original paper →

Related papers

← Back to the Research Library